荷兰鼻窦鳞状细胞癌:2008-2021年诊断的568例基于人群的研究
该前瞻性设计基于人群的队列研究纳入2008至2021年荷兰568例鼻窦鳞状细胞癌患者,分析发病趋势、患者特征与治疗实践。总人群年发病率呈轻微上升趋势,年百分比变化为1.6%。5年总生存率、无病生存率和相对生存率分别为43.0%、52.0%和47.2%,相对生存率在纳入期间轻微下降。
要点
- 总人群年发病率呈轻微上升趋势,年百分比变化为1.6%。
- 5年总生存率、无病生存率和相对生存率分别为43.0%、52.0%和47.2%。
- 2008至2021年间生存率下降有限且未达统计学显著。
核心结论
- 鼻窦鳞状细胞癌罕见,发病率约稳定。
- 2008至2021年间生存率下降有限且未达统计学显著。
- 作者认为明确需要创新治疗方法以改善鼻窦鳞状细胞癌患者的结局。
研究设计与样本
- 前瞻性设计基于人群的队列研究,纳入2008至2021年荷兰所有诊断为鼻窦鳞状细胞癌的患者。
- 排除鼻前庭鳞状细胞癌患者,最终研究人群为568例。
主要发现
- 总人群年发病率在纳入期间呈轻微上升趋势,年百分比变化为1.6%。
- 5年总生存率为43.0%,5年无病生存率为52.0%,5年相对生存率为47.2%。
- 相对生存率在纳入期间轻微下降。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sinonasal squamous cell carcinoma is known for its rarity and poor prognosis. This study aims to investigate the trends in the incidence of sinonasal squamous cell carcinoma in the Netherlands and to analyze patient characteristics and treatment practices in order to assess their relation with patient outcomes. METHODS: In this prospectively designed population-based cohort study, all patients diagnosed with sinonasal squamous cell carcinoma between 2008 and 2021 in the Netherlands were included. Patients with a squamous cell carcinoma of the nasal vestibule were excluded, leading to a definitive study population of 568 cases. RESULTS: The annual incidence rate for the overall population displayed a slight upward trend over the inclusion period with an annual percentage change of 1.6%. The 5-year overall, disease-free, and relative survival were 43.0%, 52.0%, and 47.2%, respectively. Relative survival decreased marginally over the course of the inclusion period. CONCLUSION: Sinonasal squamous cell carcinoma is rare with approximately stable incidence rates. There is a limited, non-statistically significant, decrease in survival between 2008 and 2021. Therefore, there is a clear need for innovative treatment approaches to improve outcomes for patients with sinonasal squamous cell carcinoma.
引用
- van de Velde LJ, Scheurleer WFJ, Braunius WW, et al. Sinonasal Squamous Cell Carcinoma in the Netherlands: A Population-Based Study of 568 Cases Diagnosed in 2008-2021. Head Neck. 2024. PMID: 39412961. doi:10.1002/hed.27961
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。